SCHEMBL5869880

SCHEMBL5869880

CC(C)CC(NC(CC(=O)O)Cc1cccs1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 3/20 0.42
PKM P14618 1/20 0.42
TSHR P16473 1/20 0.41
CTSK P43235 1/20 0.41
CTSC P53634 1/20 0.41
APLNR P35414 1/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
PSMD14 O00487 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8258150 1.00 CYP2C19 (0.49) CYP2C19RAB9AALDH1A1PKMTSHR
SCHEMBL5870011 0.85 CYP2C19 (0.55) CYP2C19RAB9AALDH1A1PKMTSHR
SCHEMBL8248802 0.85 CYP2C19 (0.55) CYP2C19RAB9AALDH1A1PKMTSHR
SCHEMBL5870042 0.78 MME (0.44) CTSK
SCHEMBL5870172 0.78 POLB (0.42) RAB9AALDH1A1POLBKMT2ATDP1
SCHEMBL8254423 0.78 POLB (0.42) RAB9AALDH1A1POLBKMT2ATDP1
SCHEMBL8249013 0.78 MME (0.44) CTSK
SCHEMBL5092768 0.76 PKM (0.63) RAB9AALDH1A1PKMLMNAPOLB
SCHEMBL5092771 0.76 PKM (0.63) RAB9AALDH1A1PKMLMNAPOLB
SCHEMBL22092589 0.76 CYP2C19 (0.56) CYP2C19RAB9AALDH1A1PKMCTSC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed